TDAC trades at Wall Street's consensus target of —.
Last 12 months price action with 12-month analyst target path
The base valuation assumes TDAC achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 1 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 23, 2026, Translational Development Acquisition Corp. (TDAC) has a Wall Street consensus price target of N/A, based on estimates from 1 covering analysts. The company has a market capitalization of $236M.
Analyst price targets range from a low of N/A to a high of N/A.
The current analyst consensus rating is Buy, with 1 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, TDAC trades at a trailing P/E of 29.1x.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
NUVBNuvation Bio Inc. | $2.0B | $5.76 | $13.00 | +133.8% | Buy | — | 9 |
HCAIHauchen AI Parking Management Technology Holding Co., Ltd. | $9M | $7.96 | — | — | — | — | — |
GSThe Goldman Sachs Group, Inc. | $351.4B | $1106.37 | $972.70 | -11.3% | Hold | 18.5x | 55 |
MSMorgan Stanley | $361.9B | $227.19 | $201.25 | -9.8% | Buy | 18.8x | 52 |
JPMJPMorgan Chase & Co. | $926.1B | $331.48 | $339.75 | +4.5% | Buy | 14.6x | 61 |
EVREvercore Inc. | $14.8B | $374.04 | $472.67 | +27.2% | Buy | 19.3x | 21 |
LAZLazard Ltd | $4.1B | $43.65 | $47.00 | +6.1% | Buy | 15.9x | 29 |
PJTPJT Partners Inc. | $3.7B | $154.55 | $158.67 | +2.1% | Hold | 20.6x | 12 |
RLAYRelay Therapeutics, Inc. | $3.3B | $17.28 | $24.00 | +51.1% | Buy | — | 15 |
IMVTImmunovant, Inc. | $7.8B | $38.10 | $45.00 | +27.3% | Buy | — | 23 |
Quick answers to the most common questions about buying TDAC stock.
The consensus price target for TDAC is $N/A, close to the current price of $10.75 (N/A% implied move). Based on 1 analyst estimates, the stock appears fairly valued near current levels.
TDAC has a consensus rating of "Buy" based on 1 Wall Street analysts. The rating breakdown is predominantly bullish, with 1 Buy/Strong Buy ratings. The consensus 12-month price target of $N/A implies N/A% upside from current levels.
TDAC's current price is $10.75 with a consensus target of $N/A (N/A% implied move). Analyst estimates suggest the stock is fairly valued at current levels.
The most bullish Wall Street analyst has a price target of $N/A for TDAC, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. These targets typically reflect 12-month expectations.
TDAC is lightly followed, with 1 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month TDAC stock forecast based on 1 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Buy".
TDAC appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
TDAC analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.